Related Experiment Videos
Ghrelin may attenuate proinflammatory cytokine-mediated neuropathic pain
Ensari Guneli1, Kadir Cağdas Kazikdas, Efsun Kolatan
1Department of Laboratory Animal Science, Institute of Health Science, Dokuz Eylul University, Inciralti, 35340 Izmir, Turkey. ensari.guneli@deu.edu.tr <ensari.guneli@deu.edu.tr>
Abstract:
Nerve damage that affects peripheral or central nerve systems leads to abnormal pain states referred to as neuropathic pain. The precise mechanisms in neuropathic pain are very complex, since they are thought to originate through multiple pathophysiological processes. There is quite evidence implicating the proinflammatory cytokines in the induction and facilitation of neuropathic pain. This pain syndrome is usually poorly controlled by available medications. Ghrelin, a peptide hormone predominantly secreted from the stomach, is an endogenous ligand to the growth hormone secretagogue receptor. Previous studies showed that ghrelin has potent anti-inflammatory effect; inhibiting proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta) and interleukin-6 (IL-6). Furthermore, there are recent studies which prove the interaction between ghrelin and the systems that play role in pain modulation. Therefore, we hypothesize that ghrelin might ameliorate neuropathic pain by diminishing the proinflammatory cytokines and also regulating pain system.
Related Concept Videos
Regulation of Food Intake
GPCRs Regulate Adenylyl Cylase Activity
Two...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Hormonal Regulation
Opioid Receptors: Overview
Nociception